Tumors of haematopoietic and lymphoid tissues
Conditions
Interventions
Gold Standard:The final pathological diagnosis is made by two or more pathologists of the haematopoietic and lymphoid tumors, based on the results of cytology, histology, flow cytometry(manual interpr
Index test:A diagnostic test of an AI system to classify haematopoietic and lymphoid tumors based on flow cytometry of lymph node sample.
Sponsors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patients are suspected to have tumors of haematopoietic and lymphoid tissues clinically or radiologically. (2) The specimens are lymph node resection/puncture tissues and are not fixed by formalin; (3)Patient who agree to be enrolled and sign the informed consent form; (4)All patients are enrolled consecutively.
Exclusion criteria
Exclusion criteria: (1) Specimens are bone marrow biopsy samples, blood and other non lymph node tissues; (2) Specimens have been in vitro for too long, or have been fixed by formalin; (3) Patients who had a history of haematopoietic and lymphoid tumors and received treatment recently; (4) Patients who refuse to participate in this study or sign the informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| diagnostic accuracy;area under receiver operating curve;sensitivity;specificity;positive predictive value;negative predictive value; | — |
Countries
China
Contacts
Public ContactNie Xiu
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Outcome results
None listed